Nexgel Inc - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Nexgel Inc (NXGL) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Nexgel Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$9.96 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2021–2023)

This chart shows how Nexgel Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Nexgel Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Nexgel Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Nexgel Inc market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Nexgel Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Nexgel Inc Industry Peers by Asset Resilience Ratio

Compare Nexgel Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Andon Health Co Ltd
SHE:002432
Medical Instruments & Supplies 18.11%
AVE Science & Technology Co Ltd
SHG:688067
Medical Instruments & Supplies 24.13%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 3.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%

Annual Asset Resilience Ratio for Nexgel Inc (2021–2023)

The table below shows the annual Asset Resilience Ratio data for Nexgel Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 0.00% $0.00 $9.96 Million --
2022-12-31 53.18% $5.51 Million $10.36 Million --
2021-12-31 0.00% $0.00 $16.98 Million --
pp = percentage points

About Nexgel Inc

NASDAQ:NXGL USA Medical Instruments & Supplies
Market Cap
$5.58 Million
Market Cap Rank
#28517 Global
#5790 in USA
Share Price
$0.61
Change (1 day)
+15.07%
52-Week Range
$0.51 - $2.78
All Time High
$4.95
About

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more